Je was op zoek naar: symptomdebut (Deens - Engels)

symptomdebut
onset of symptoms

behandling med metalyse bør initieres hurtigst muligt efter symptomdebut.
treatment with metalyse should be initiated as soon as possible after onset of symptoms.

tiden til symptomdebut varierede fra én dag til adskillige måneder efter behandlingsstart.
the time to onset of symptoms varied from one day to several months after starting treatment.

symptomdebut efter start af behandling med lægemidlet kan opstå hurtigt eller efter længere behandlingsperioder.
onset of symptoms following initiation of drug therapy may be rapid or may occur after longer periods of treatment.

behandling med acetylsalicylsyre bør initieres hurtigst muligt efter symptomdebut og fortsættes som livslang behandling, medmindre det er kontraindiceret.
acetylsalicylic acid should be initiated as soon as possible after symptom onset and continued with lifelong treatment unless it is contraindicated.

Åbning af koronararterierne og begrænsede kliniske data har vist at ami-patienter er blevet velbehandlet senere end 6 timer efter symptomdebut.
coronary patency and limited clinical outcome data showed that ami patients have been successfully treated later than 6 hours after symptom onset.

resultaterne er fra en cox proportionel risiko regressions analyse, der inkluderer behandling som en tidsvarierende kovariat samt alder ved diagnose og alder ved symptomdebut.
results are from a cox proportional hazards regression analysis which includes treatment as a time-varying covariate, and also includes age of diagnosis and age at symptom onset.

bemærk: resultaterne er fra en cox proportionel risiko regressions analyse, der inkluderer behandling som en tidsvarierende kovariat samt alder ved diagnose og alder ved symptomdebut.
note: results are from a cox proportional hazards regression analysis which includes treatment as a time-varying covariate, and also includes age of diagnosis and age at symptom onset.

dyrene blev monitoreret i 16-17 dage efter challenge for at tillade omfattende vurdering af sygdomsprogression, herunder tidspunkt for symptomdebut, mortalitet eller efterfølgende helbredelse.
animals were monitored for 16-17 days after challenge to allow for a comprehensive assessment of disease progression, including the time of onset of symptoms, mortality, or subsequent recovery.

metalyse bruges til at behandle myokardieinfarkter (hjerteanfald) indenfor 6 timer efter symptomdebut, og hjælper med at opløse blodpropper som er opstået i hjertets blodkar.
metalyse is used to treat myocardial infarctions (heart attacks) within 6 hours after the onset of symptoms and helps to dissolve the blood clots that have formed in the blood vessels of the heart.

metalyse er indiceret til trombolytisk behandling af mistænkt myokardieinfarkt med vedvarende st elevation eller nylig venstresidig bundle branch block indenfor 6 timer efter symptomdebut på akut myokardieinfarkt (ami).
metalyse is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 6 hours after the onset of acute myocardial infarction (ami) symptoms.

symptomerne fremkom sædvanligvis inden for de første 6 uger efter start af behandlingen med abacavir (gennemsnitligt 11 dage til symptomdebut), skønt reaktionerne kan opstå på et hvilket som helst tidspunkt under behandlingen.
symptoms usually appeared within the first six weeks (median time to onset 11 days) of initiation of treatment with abacavir, although these reactions may occur at any time during therapy.

alvorlige reaktioner forbundet med injektionen blev rapporteret hos 2 patienter, uden at behandlingen med asfotase alfa blev seponeret: 1 patient med hypophosphatasi med symptomdebut i spædbarnsalderen rapporterede feber og kulderystelser, og 1 patient med hypophosphatasi med symptomdebut i ungdomsalderen rapporterede oral hypæstesi, smerter i ekstremiteter, kulderystelser og hovedpine.
serious injection-associated reactions were reported in 2 patients with no discontinuation of asfotase alfa treatment: 1 patient with infantile-onset hypophosphatasia recorded fever and chills, and in 1 patient with juvenile-onset hypophosphatasia recorded hypoaesthesia oral, pain in extremity, chills, and headache.